Zhu Yi, the founder, president, and chief scientific officer of Biokin Pharmaceutical, donated 30 million yuan in cash to establish the “Fudan University-Biokin Pharmaceutical Distinguished Professor" program, supporting the faculty development in cutting-edge fields such as "innovative drug targets discovery" and "brain and brain-inspired intelligence researches" at Fudan University, while strengthening the construction and advancement of strategic talent teams.

"Everybody only has one life. Researches on discovery of innovative drug targets are extraordinarily valuable for enhancing quality of life and extending longevity. Meanwhile, researches on brain and brain-inspired intelligence carry profound significance for human to explore the unknown world and address ultimate questions about the nature of human intelligence," Zhu Yi emphasized. He noted that as a comprehensive research university, Fudan possesses robust scientific foundations in both drug target discovery and brain science research, with distinctive advantages in interdisciplinary studies. Pioneering researches in frontier fields need exceptional scientists and teachers. Through this program, we hope to empower these outstanding scholars to conduct groundbreaking researches at Fudan with undivided focus and freedom from distractions.”